Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online May 24, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0132v1
25/9/2350    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson, D.
Right arrow Articles by Dudley, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson, D.
Right arrow Articles by Dudley, S. C., Jr.
Submitted on February 19, 2007
Accepted on May 17, 2007

TRANSLATIONAL AND CLINICAL RESEARCH

A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling

David Simpson 1, Hong Liu 2, Tai Hwang Michael Fan 2, Robert Nerem 3, Samuel C. Dudley Jr.2*

1 Georgia Institute of Technology, Atlanta, GA, 30332, USA; Emory University, Atlanta, GA, 30322 USA
2 Atlanta Veteran Affairs Medical Center, Decatur, GA, 30033, USA; Emory University, Atlanta, GA, 30322 USA
3 Georgia Institute of Technology, Atlanta, GA, 30332, USA

* To whom correspondence should be addressed. E-mail: sdudley{at}emory.edu.


   Abstract

Cell replacement therapy has become an attractive solution for myocardial repair. Typical cell delivery techniques, however, suffer from poor cell engraftment and inhomogeneous cell distributions. Therefore, we assessed the hypothesis that an epicardially applied, tissue engineered, cardiac patch containing progenitor cells would result in enhanced exogenous cell engraftment. Human mesenchymal stem cells (hMSCs) were embedded into a rat tail type I collagen matrix to form the cardiac patch. Myocardial infarction was induced by left anterior descending coronary artery ligation in immunocompetent male CDF rats, and patches with or without cells were secured to hearts with fibrin sealant. After patch formation, hMSC retained a viability of >90% over five days in culture. In addition, >75% of hMSC maintained a high degree of potency prior to patch implantation. After four days in culture, patches were applied to the epicardial surface of the infarct area and resulted in 23 ± 4% engraftment of hMSC at one week (n=6). Patch application resulted in a reduction in LV interior diameter at systole, increased anterior wall thickness and a 30% increase in fractional shortening. Despite this improvement in myocardial remodeling, hMSC were not detectable at 4 weeks after patch application, implying improvement did not require long-term cell engraftment. Patches devoid of progenitor cells showed no improvement in remodeling. In conclusion, pluripotent hMSC can be efficiently delivered to a site of myocardial injury and such delivery results in improved myocardial remodeling after infarction.

Key Words. Tissue Engineering [E05.200.249.750], Mesenchymal Stem Cell Transplantation [E04.936.225.687.625], Myocardial Infarction [C14.280.647.500], Ventricular Remodeling [G09.330.582.962.975]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. C. Dudley Jr and D. Simpson
An Imperfect Syllogism: Granulocyte Colony-Stimulating Factor Mobilization and Cardiac Regeneration
J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1438 - 1439.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.